Retinoids, retinoic acid receptors, and breast cancer

Cancer Investigation

Volumn 21, Issue 2, 2003, Pages 304-312

  Paik, Jisun ^a   Blaner, William S ^a   Sommer, Karen M ^b   Moe, Roger ^c   Swisshlem, Karen ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID RECEPTOR; RETINOID;

BREAST CANCER; BREAST CARCINOGENESIS; CELL DIFFERENTIATION; GENE ACTIVATION; GENE EXPRESSION REGULATION; MULTIGENE FAMILY; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS;

BREAST NEOPLASMS; CLINICAL TRIALS; FEMALE; HUMANS; RECEPTORS, RETINOIC ACID; RETINOIDS;

EID: 0038416978     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120016425     Document Type: Review

References (55)

1. Wolbach, S.B.; Howe, P.R. Tissue changes following deprivation of fat-soluble A vitamin. J. Exp. Med. 1925, 42, 753-778.
2. Hunter, D.J.; Manson, J.E.; Colditz, G.A.; Stampfer, M.J.; Rosner, B.; Hennekens, C.H.; Speizer, F.E.; Willett, W.C. A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N. Engl. J. Med. 1993, 329 (4), 234-240.
3. Kushi, L.H.; Fee, R.M.; Sellers, T.A.; Zheng, W.; Folsom, A.R. Intake of vitamins A, C, and E and postmenopausal breast cancer. The Iowa Women's Health Study. Am. J. Epidemiol. 1996, 144 (2), 165-174.
4. Verhoeven, D.T.; Assen, N.; Goldbohm, R.A.; Dorant, E.; van't Veer, P.; Sturmans, F.; Hermus, R.J.; van den Brandt, P.A. Vitamins C and E, retinol, beta-carotene and dietary fibre in relation to breast cancer risk: a prospective cohort study. Br. J. Cancer 1997, 75 (1), 149-155.
5. Ferguson, L.; Harris, P. Protection against cancer by wheat bran: role of dietary fibre and phyochemicals. Eur. J. Cancer Prev. 1999, 8, 17-25.
6. Messina, M. Soy, soy phytoestrogens (isoflavones), and breast cancer. Am. J. Clin. Nutr. 1999, 70 (4), 574-575.
7. Messina, M.J. Legumes and soybeans: overview of their nutritional profiles and health effects. Am. J. Clin. Nutr. 1999, 70 (3 Suppl.), 439S-450S.
8. Rose, D.; Connolly, J.; Liu, X. Diet and breast cancer: opportunities for prevention and intervention. In Ninth International Conference on Carcinogenesis and Risk Assessment; Wiley-Liss: Austin, TX, 1995.
9. Moon, R.C.; Mehta, R.G.; Rao, K.V.N. Retinoids and cancer in experimental animals. In The Retinoids: Biology, Chemistry, and Medicine; Sporn, M.B., Roberts, A.B., Goodman, D.S., Eds.; Raven: New York, 1994; 573-595.
10. Moon, R.C.; Thompson, H.J.; Becci, P.J.; Grubbs, C.J.; Gander, R.J.; Newton, D.L.; Smith, J.M.; Phillips, S.L.; Henderson, W.R.; Mullen, L.T.; Brown, C.C.; Sporn, M.B. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res. 1979, 39 (4), 1339-1346.
11. McCormick, D.L.; Moon, R.C. Influence of delayed administration of retinyl acetate on mammary carcinogenesis. Cancer Res. 1982, 42 (7), 2639-2643.
12. Ratko, T.A.; Detrisac, C.J.; Dinger, N.M.; Thomas, C.F.; Kelloff, G.J.; Moon, R.C. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. Cancer Res. 1989, 49 (16), 4472-4476.
13. Anzano, M.A.; Byers, S.W.; Smith, J.M.; Peer, C.W.; Mullen, L.T.; Brown, C.C.; Roberts, A.B.; Sporn, M.B. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. Cancer Res. 1994, 54 (17), 4614-4617.
14. Anzano, M.A.; Peer, C.W.; Smith, J.M.; Mullen, L.T.; Shrader, M.W.; Logsdon, D.L.; Driver, C.L.; Brown, C.C.; Roberts, A.B.; Sporn, M.B. Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid. J. Natl Cancer Inst. 1996, 88 (2), 123-125.
15. Agarwal, V.R.; Bischoff, E.D.; Hermann, T.; Lamph, W.W. Induction of adipocyte-specific gene expression is correlated with mammary tumor regression by the retinoid X receptor-ligand LGD1069 (targretin). Cancer Res. 2000, 60 (21), 6033-6038.
16. Bischoff, E.D.; Gottardis, M.M.; Moon, T.E.; Heyman, R.A.; Lamph, W.W. Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma. Cancer Res. 1998, 58 (3), 479-484.
17. 2 inhibition of metastasis in mouse mammary gland xenografts. Breast Cancer Res. Treat. in press.
18. Budd, G.; Adamson, P.C.; Gupta, M.; Homayoun, P.; Sandstrom, S.K.; Murphy, R.F.; McLain, D.; Tuason, L.; Peereboom, D.; Bukowski, R.M.; Ganapathy, R. Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer. Clin. Cancer Res. 1998, 4, 635-642.
19. Toma, S.; Raffo, P.; Nicolo, G.; Canavese, G.; Margallo, E.; Vecchio, C.; Dastoli, G.; Iacona, I.; Regazzi-Bonora, M. Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients. Int. J. Oncol. 2000, 17 (5), 991-1000.
20. National Cancer Institute DCPC Chemoprevention Branch and Agent Development Committee Clinical development plan: vitamin A. J. Cell. Biochem. 1996, 26S, 269-307.
21. Cobleigh, M.A. Breast cancer and fenretinide, an analogue of vitamin A. Leukemia 1994, 8 (Suppl. 3), S59-S63.
22. Veronesi, U.; De Palo, G.; Marubini, E.; Costa, A.; Formelli, F.; Mariani, L.; Decensi, A.; Camerini, T.; Del Turco, M.R.; Di Mauro, M.G.; Muraca, M.G.; Del Vecchio, M.; Pinto, C.; D'Aiuto, G.; Boni, C.; Campa, T.; Magni, A.; Miceli, R.; Perloff, M.; Malone, W.F.; Sporn, M.B. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J. Natl Cancer Inst. 1999, 91 (21), 1847-1856.
23. Conley, B.; O'Shaughnessy, J.; Prindiville, S.; Lawrence, J.; Chow, C.; Jones, E.; Merino, M.J.; Kaiser-Kupfer, M.I.; Caruso, R.C.; Podgor, M.; Goldspiel, B.; Venzon, D.; Danforth, D.; Wu, S.; Noone, M.; Goldstein, J.; Cowan, K.H.; Zujewski, J. Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer. J. Clin. Oncol. 2000, 18 (2), 275-283.
24. Piantadosi, S. Vitamin A analogue for breast cancer prevention: a grade of F or incomplete? J. Natl Cancer Inst. 1999, 91 (21), 1794.
25. Sporn, M.B.; Suh, N. Chemoprevention of cancer. Carcinogenesis 2000, 21 (3), 525-530.
26. Blaner, W.S.; Piantadosi, R.; Sykes, A.; Vogel, S. Retinoic acid synthesis and metabolism. Handbook Exp. Pharmacol. 1999, 139, 117-152.
27. Napoli, J.L. Retinoic acid biosynthesis and metabolism. FASEB J. 1996, 10 (9), 993-1001.
28. Vogel, S.; Gamble, M.V.; Blaner, W.S. Biosynthesis, absorption, metabolism and transport of retinoids. Handbook Exp. Pharmacol. 1999, 139, 31-96.
29. Takatsuka, J.; Takahashi, N.; de Luca, L.M. Retinoic acid metabolism and inhibition of cell proliferation: an unexpected liaison. Cancer Res. 1996, 56 (4), 675-678.
30. Bhat, P.V.; Lacroix, A. Metabolism of retinol and retinoic acid in N-methyl-N-nitrosourea-induced mammary carcinomas in rats. Cancer Res. 1989, 49 (1), 139-144.
31. Chen, A.C.; Guo, X.; Derguini, F.; Gudas, L.J. Human breast cancer cells and normal mammary epithelial cells: retinol metabolism and growth inhibition by the retinol metabolite 4-oxoretinol. Cancer Res. 1997, 57 (20), 4642-4651.
32. Deng, G.; Lu, Y.; Zlotnikov, G.; Thor, A.D.; Smith, H.S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996, 274 (5295), 2057-2059.
33. Widschwendter, M.; Berger, J.; Daxenbichler, G.; Muller-Holzner, E.; Widschwendter, A.; Mayr, A.; Marth, C.; Zeimet, A.G. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res. 1997, 57 (19), 4158-4161.
34. Xu, X.C.; Sneige, N.; Liu, X.; Nandagiri, R.; Lee, J.J.; Lukmanji, F.; Hortobagyi, G.; Lippman, S.M.; Dhingra, K.; Lotan, R. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Cancer Res. 1997, 57 (22), 4992-4996.
35. Lawrence, J.A.; Merino, M.J.; Simpson, J.F.; Manrow, R.E.; Page, D.L.; Steeg, P.S. A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor. Cancer Epidemiol. Biomarkers Prev. 1998, 7 (1), 29-35.
36. Ariga, N.; Moriya, T.; Suzuki, T.; Kimura, M.; Ohuchi, N.; Sasano, H. Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast. Jpn. J. Cancer Res. 2000, 91 (11), 1169-1176.
37. Suzuki, T.; Moriya, T.; Sugawara, A.; Ariga, N.; Takabayashi, H.; Sasano, H. Retinoid receptors in human breast carcinoma: possible modulators of in situ estrogen metabolism. Breast Cancer Res. Treat. 2001, 65 (1), 31-40.
38. Sommer, K.M.; Chen, L.I.; Treuting, P.M.; Smith, L.T.; Swisshelm, K. Elevated retinoic acid receptor beta(4) protein in human breast tumor cells with nuclear and cytoplasmic localization. Proc. Natl Acad. Sci. U.S.A. 1999, 96 (15), 8651-8656.
39. Widschwendter, M.; Berger, J.; Hermann, M.; Muller, H.M.; Amberger, A.; Zeschnigk, M.; Widschwendter, A.; Abendstein, B.; Zeimet, A.G.; Daxenbichler, G.; Marth, C. Methylation and silencing of the retinoic acid receptorbeta2 gene in breast cancer. J. Natl Cancer Inst. 2000, 92 (10), 826-832.
40. Yang, Q.; Sakurai, T.; Yoshimura, G.; Mori, I.; Nakamura, M.; Nakamura, Y.; Suzuma, T.; Tamaki, T.; Umemura, T.; Kakudo, K. Hypermethylation does not account for the frequent loss of the retinoic acid receptor beta2 in breast carcinoma. Anticancer Res. 2001, 21 (3B), 1829-1833.
41. Yang, Q.; Mori, I.; Shan, L.; Nakamura, M.; Nakamura, Y.; Utsunomiya, H.; Yoshimura, G.; Suzuma, T.; Tamaki, T.; Umemura, T.; Sakurai, T.; Kakudo, K. Biallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancer. Am. J. Pathol. 2001, 158 (1), 299-303.
42. Krezel, W.; Kastner, P.; Chambon, P. Differential expression of retinoid receptors in the adult mouse central nervous system. Neuroscience 1999, 89 (4), 1291-1300.
43. Chen, L.I.; Sommer, K.M.; Swisshelm, K. A downstream translation start site in retinoic acid receptor beta-2 and -4 mRNA creates a protein isoform that disrupts retinoidactivated transcription, unpublished.
44. Zimmer, A.; Zimmer, A.M.; Reynolds, K. Tissue specific expression of the retinoic acid receptor-beta 2: regulation by short open reading frames in the 5′-noncoding region. J. Cell Biol. 1994, 127 (4), 1111-1119.
45. Roman, S.D.; Clarke, C.L.; Hall, R.E.; Alexander, I.E.; Sutherland, R.L. Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res. 1992, 52 (8), 2236-2242.
46. Swisshelm, K.; Ryan, K.; Lee, X.; Tsou, H.C.; Peacocke, M.; Sager, R. Down-regulation of retinoic acid receptor beta in mammary carcinoma cell lines and its upregulation in senescing normal mammary epithelial cells. Cell Growth Differ. 1994, 5 (2), 133-141.
47. Seewaldt, V.L.; Johnson, B.S.; Parker, M.B.; Collins, S.J.; Swisshelm, K. Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ. 1995, 6 (9), 1077-1088.
48. Liu, Y.; Lee, M.O.; Wang, H.G.; Li, Y.; Hashimoto, Y.; Klaus, M.; Reed, J.C.; Zhang, X. Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell. Biol. 1996, 16 (3), 1138-1149.
49. Li, Y.; Hashimoto, Y.; Agadir, A.; Kagechika, H.; Zhang, X. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells. J. Biol. Chem. 1999, 274 (22), 15360-15366.
50. Seewaldt, V.L.; Caldwell, L.E.; Johnson, B.S.; Swisshelm, K.; Collins, S.J.; Tsai, S. Inhibition of retinoic acid receptor function in normal human mammary epithelial cells results in increased cellular proliferation and inhibits the formation of a polarized epithelium in vitro. Exp. Cell Res. 1997, 236 (1), 16-28.
51. Roman, S.D.; Ormandy, C.J.; Manning, D.L.; Blamey, R.W.; Nicholson, R.I.; Sutherland, R.L.; Clarke, C.L. Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res. 1993, 53 (24), 5940-5945.
52. Sheikh, M.S.; Shao, Z.M.; Chen, J.C.; Hussain, A.; Jetten, A.M.; Fontana, J.A. Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RAR alpha gene expression and sensitivity to growth inhibition by retinoic acid. J. Cell. Biochem. 1993, 53 (4), 394-404.
53. van der Burg, B.; van der Leede, B.M.; Kwakkenbos-Isbrucker, L.; Salverda, S.; de Laat, S.W.; van der Saag, P.T. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol. Cell. Endocrinol. 1993, 91 (1-2), 149-157.
54. van der Leede, B.J.; Folkers, G.E.; van den Brink, C.E.; van der Saag, P.T.; van der Burg, B. Retinoic acid receptor alpha 1 isoform is induced by estradiol and confers retinoic acid sensitivity in human breast cancer cells. Mol. Cell. Endocrinol. 1995, 109 (1), 77-86.
55. Wickerham, D.L.; Tan-Chiu, E. Breast cancer chemoprevention: current status and future directions. Semin. Oncol. 2001, 28 (3), 253-259.